Palliative treatment of unresectable esophagogastric junction tumors: Balloon dilation combined with chemotherapy and/or radiation therapy and metallic stent placement

被引:20
|
作者
Kim, Jin Hyoung [1 ]
Song, Ho-Young [1 ]
Shin, Ji Hoon [1 ]
Kim, Tae Won [2 ]
Kim, Kyung Rae [1 ]
Kim, Sung-Bae [2 ]
Park, Seung-Il [3 ]
Kim, Jong Hoon [4 ]
Choi, Eugene [5 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul 138736, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul 138736, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul 138736, South Korea
[5] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
关键词
D O I
10.1016/j.jvir.2008.02.020
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To prospectively evaluate an algorithm for palliative treatment of unresectable esophagogastric junction tumors based on stricture length. MATERIALS AND METHODS: Eighty-six patients with malignant esophagogastric obstructions were referred to the interventional radiology department for balloon dilation or stent placement due to dysphagia. Balloon dilation was performed in patients (n = 39) with a short segmental (:54 cm) stricture, whereas stent placement was performed in patients (n = 47) with a long segmental (> 4 cm) stricture. In the balloon group, 16 patients with esophageal carcinoma underwent both chemotherapy and radiation therapy, whereas 23 patients with gastric carcinoma underwent only chemotherapy. RESULTS: Technical success was achieved in all procedures in all patients (100%). The overall clinical success rate of balloon dilation and stent placement for a malignant esophagogastric junction was 87% (75 of 86 patients). Clinical success was achieved in 29 of the 39 patients in the balloon group (74%) and 98% (46 of the 47 patients in the stent group (98%). The overall complication rate was 21% (18 of 86 patients). Seventeen complications, which consisted of reflux (n = 8), migration (n = 6), tumor overgrowth (n = 2), and tissue hyperplasia (n = 1), occurred after stent placement, whereas one complication (intramural rupture) occurred after balloon dilation. The median symptom-free and survival periods were 120 (95% confidence interval: 114, 263) and 147 (95% confidence interval: 98, 196) days, respectively. CONCLUSIONS: The treatment strategies seem to be reasonable for palliative therapy in patients with malignant esophagogastric junction obstructions. However, further investigations are needed to minimize the drawbacks of the methods and to determine optimal treatments in patients with unresectable malignant esophagogastric junction obstructions.
引用
收藏
页码:912 / 917
页数:6
相关论文
共 12 条
  • [1] Malignant esophagogastric junction obstruction: Efficacy of balloon dilation combined with chemotherapy and/or radiation therapy
    Ko, GY
    Song, HY
    Hong, HJ
    Sung, KB
    Seo, TS
    Yoon, HK
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2003, 26 (02) : 141 - 145
  • [2] Malignant Esophagogastric Junction Obstruction: Efficacy of Balloon Dilation Combined with Chemotherapy and/or Radiation Therapy
    Gi-Young Ko
    Ho-Young Song
    Heuk-Jin Hong
    Kyu-Bo Sung
    Tae-Seok Seo
    Hyun-Ki Yoon
    [J]. CardioVascular and Interventional Radiology, 2003, 26 : 141 - 145
  • [3] Uncovered self-expandable metallic stent placement as a first-line palliative therapy in unresectable malignant duodenal obstruction
    Ahn, Hyung Su
    Hong, Su Jin
    Moon, Jong Ho
    Ko, Bong Min
    Choi, Hyun Jong
    Han, Jae Pil
    Park, Jin Seok
    Kang, Myung Soo
    Cho, Joo Young
    Lee, Joon Seong
    Lee, Moon Sung
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2012, 13 (12) : 628 - 633
  • [4] Combined treatment with chemotherapy and radiation therapy for intracranial germ cell tumors
    Matsutani, M
    Sano, K
    Takakura, K
    Fujimaki, T
    Nakamura, O
    [J]. CHILDS NERVOUS SYSTEM, 1998, 14 (1-2) : 59 - 62
  • [5] Combined treatment with chemotherapy and radiation therapy for intracranial germ cell tumors
    Masao Matsutani
    Keiji Sano
    Kintomo Takakura
    Takamitsu Fujimaki
    Osamu Nakamura
    [J]. Child's Nervous System, 1998, 14 : 59 - 62
  • [6] Intraluminal radiation therapy combined with metallic biliary endoprosthesis, external radiation therapy, hepatic arterial infusion chemotherapy for unresectable bile duct cancer
    Goto, M
    Yamakado, K
    Shoji, KJ
    Nomoto, Y
    Matsumura, K
    Takeda, K
    [J]. RADIOLOGY, 1998, 209P : 255 - 255
  • [7] Palliative Treatment of Inoperable Malignant Tracheobronchial Obstruction: Temporary Stenting Combined With Radiation Therapy and/or Chemotherapy
    Kim, Jin Hyoung
    Shin, Ji Hoon
    Song, Ho-Young
    Ohm, Joon-Young
    Lee, Jae Moung
    Lee, Dae Ho
    Kim, Sang-We
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 193 (01) : W38 - W42
  • [8] Biologic Mesh Spacer Placement Facilitates Safe Delivery of Dose-intense Radiation Therapy: A Novel Treatment Option for Unresectable Liver Tumors
    Ismael, H. N.
    Crane, C.
    Das, P.
    Krishnan, S.
    Schroff, R.
    Javle, M.
    Conrad, C.
    Vauthey, J.
    Aloia, T.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S107 - S107
  • [9] Biologic mesh spacer placement facilitates safe delivery of dose-intense radiation therapy: A novel treatment option for unresectable liver tumors
    Ismael, H. N.
    Denbo, J.
    Cox, S.
    Crane, C. H.
    Das, P.
    Krishnan, S.
    Schroff, R. T.
    Javle, M.
    Conrad, C.
    Vauthey, J.
    Aloia, T.
    [J]. EJSO, 2016, 42 (10): : 1591 - 1596
  • [10] SELECTIVE INTERNAL RADIATION THERAPY COMBINED WITH SYSTEMIC CHEMOTHERAPY AS A FIRST-LINE TREATMENT FOR UNRESECTABLE LIVER-DOMINANT COLORECTAL CANCER
    Kosmider, S.
    Yip, D.
    Tan, H.
    Dowling, R.
    Lichtenstien, M.
    Gibbs, P.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 67 - 67